title: [Generic drugs in developing countries].
abstract: Drugs are generally considered as consumer goods which serve to protect, maintain and restore health. In recent years, the proportion of national expenditure devoted to health has increased in all developing countries. The use of generic drugs can reduce health costs, if part of a national drug action plan, and their quality is confirmed (quality control, distribution system, correct utilization). Nevertheless, a large proportion of the population in developing countries has no access to these drugs. This situation requires establishing financing schemes for drug supplies, with community involvement and participation of the population. However, such schemes can result in limited access and inequity.
authors.affiliation: Centre hospitalier universitaire de Grenoble, France.
authors.forename: P
authors.initials: P
authors.lastname: Trouiller
mesh_terms: D017954:Africa South of the Sahara; D003256:Community Participation; D003363:Cost Control; D003906:Developing Countries; D016527:Drug Costs; D004363:Drug Utilization; D004335:Drug and Narcotic Control; D016568:Drugs, Generic / Q000191:economics / Q000592:standards / Q000600:supply & distribution*; D005602:France; D006297:Health Services Accessibility; D006801:Humans; D013810:Therapeutic Equivalency
chemical_list: D016568:Drugs, Generic